0001838216-21-000004.txt : 20210701
0001838216-21-000004.hdr.sgml : 20210701
20210701130535
ACCESSION NUMBER: 0001838216-21-000004
CONFORMED SUBMISSION TYPE: C-U
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20210701
DATE AS OF CHANGE: 20210701
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Grove Biomedical LLC
CENTRAL INDEX KEY: 0001823771
IRS NUMBER: 850823430
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: C-U
SEC ACT: 1933 Act
SEC FILE NUMBER: 020-27342
FILM NUMBER: 211065058
BUSINESS ADDRESS:
STREET 1: 282 KATONAH AVENUE
STREET 2: #537
CITY: KATONAH
STATE: NY
ZIP: 10546
BUSINESS PHONE: 6502040014
MAIL ADDRESS:
STREET 1: 282 KATONAH AVENUE, #537
STREET 2: #537
CITY: KATONAH
STATE: NY
ZIP: 10546
C-U
1
primary_doc.xml
C-U
0001823771
XXXXXXXX
020-27342
LIVE
false
false
false
The Offering closed successfully on 07.01.2021, having received investment commitments of $330,114.84, although a final accounting has not taken place.
Grove Biomedical LLC
Limited Liability Company
NY
04-24-2020
282 KATONAH AVENUE, #537
#537
KATONAH
NY
10546
https://www.onecanopy.com
N
OpenDeal Portal LLC
0001751525
007-00167
283874
The issuer shall pay to the Intermediary at the conclusion of the Offering a fee of six percent (6%) of the amount raised in the offering.
The Intermediary will also receive compensation in the form of Securities equal to two percent (2%) of the total number of Securities sold in the Offering.
Other
Class CF Units
4457
5.61000
25003.77
Y
Other
At the Intermediary's discretion
1069995.30
06-30-2021
0.00
289694.00
0.00
126035.00
0.00
0.00
0.00
190813.00
0.00
296566.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-522685.00
0.00
AL
AK
AZ
AR
CA
CO
CT
DE
DC
FL
GA
HI
ID
IL
IN
IA
KS
KY
LA
ME
MD
MA
MI
MN
MS
MO
MT
NE
NV
NH
NJ
NM
NY
NC
ND
OH
OK
OR
PA
PR
RI
SC
SD
TN
TX
UT
VT
VA
WA
WV
WI
WY
Grove Biomedical LLC
Joseph Rosenberg
CEO
Joseph Rosenberg
CEO
07-01-2021